EP2464382 - Bibliographic data
THÉRAPIE COMBINÉE D'UN ANTICORPS CD20 AFUCOSYLATÉ ET DE BENDAMUSTINE
| Last update | 17/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
ROCHE GLYCART AG Wagistrasse 18
8952 Schlieren-Zuerich
Suisse
|
|---|---|
| (72) Inventors |
Frank HERTING An der Freiheit 29a
82377 Penzberg
Allemagne
Christian KLEIN Chapfstrasse 26B
8906 Bonstetten
Suisse
|
| (74) Agent |
Mail recipient Jacobacci Coralis Harle 32, rue de l'Arcade
75008 Paris
France
|
| (21) Request number | EP10747168.2 |
|---|---|
| (22) Request date | 12/08/2010 |
| (11) Publication number | EP2464382 |
|---|---|
| Publication date | 03/05/2017 |
| (54) Title of the invention | THÉRAPIE COMBINÉE D'UN ANTICORPS CD20 AFUCOSYLATÉ ET DE BENDAMUSTINE |
|---|---|
| (51) International classification | A61K 39/395, C07K 16/28, A61K 31/4184, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 09010489 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 16 - Amount: 405 € - Due date 01/09/2025 |
|---|---|
| Last annuity | Annuity: 15 - Payment date 29/07/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 03/05/2017 Constitution de mandataire pour un dossier - Legal date 04/07/2017 |